Patents by Inventor Seth Kindler
Seth Kindler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240050397Abstract: Some embodiments of the invention relate to a system for delivering to a subject at least one pre-determined amount of THC, the system comprising: a memory which stores a scheduled regimen for delivery of THC to the subject, the scheduled regimen defining: a maximal amount of THC to be delivered, the amount being 0.75 mg THC or less, and a time period within which that amount is delivered, the time period being 2 hours or longer; a decision module which decides, according to the scheduled regimen, if a delivery should take place; and an inhaler device for delivering THC to the subject, the inhaler device comprising a controller which carries out delivery of THC based on the decision made by the decision module.Type: ApplicationFiled: October 12, 2023Publication date: February 15, 2024Applicant: Syqe Medical Ltd.Inventors: Perry DAVIDSON, Seth KINDLER, Shlomo ALMOG, Binyamin SCHWARTZ, Aaron SCHORR, Daniella ATZMONY
-
Patent number: 11806331Abstract: Some embodiments of the invention relate to a system for delivering to a subject at least one pre-determined amount of THC, the system comprising: a memory which stores a scheduled regimen for delivery of THC to the subject, the scheduled regimen defining: a maximal amount of THC to be delivered, the amount being 0.75 mg THC or less, and a time period within which that amount is delivered, the time period being 2 hours or longer; a decision module which decides, according to the scheduled regimen, if a delivery should take place; and an inhaler device for delivering THC to the subject, the inhaler device comprising a controller which carries out delivery of THC based on the decision made by the decision module.Type: GrantFiled: January 5, 2017Date of Patent: November 7, 2023Assignee: Syqe Medical Ltd.Inventors: Perry Davidson, Seth Kindler, Shlomo Almog, Binyamin Schwartz, Aaron Schorr, Daniella Atzmony
-
Publication number: 20220211958Abstract: Provided herein is a method of pulmonary delivering to a subject at least one pharmacologically active agent being in a plant material, which is effected by pulmonary delivering the agent to the subject using a metered dose inhaler device that is configured to vaporize at least one pre-determined vaporized amount of the agent upon controllably heating the plant material, wherein the pre-determined vaporized amount is selected so as to achieve at least one pre-determined pharmacokinetic effect and/or at least one pre-determined pharmacodynamic effect induced by the agent in the subject.Type: ApplicationFiled: March 15, 2022Publication date: July 7, 2022Applicant: Syqe Medical Ltd.Inventors: Perry DAVIDSON, Shlomo ALMOG, Seth KINDLER
-
Patent number: 11298477Abstract: Provided herein is a method of pulmonary delivering to a subject at least one pharmacologically active agent being in a plant material, which is effected by pulmonary delivering the agent to the subject using a metered dose inhaler device that is configured to vaporize at least one pre-determined vaporized amount of the agent upon controllably heating the plant material, wherein the pre-determined vaporized amount is selected so as to achieve at least one pre-determined pharmacokinetic effect and/or at least one pre-determined pharmacodynamic effect induced by the agent in the subject.Type: GrantFiled: July 10, 2018Date of Patent: April 12, 2022Assignee: Syqe Medical Ltd.Inventors: Perry Davidson, Shlomo Almog, Seth Kindler
-
Publication number: 20190015382Abstract: Some embodiments of the invention relate to a system for delivering to a subject at least one pre-determined amount of THC, the system comprising: a memory which stores a scheduled regimen for delivery of THC to the subject, the scheduled regimen defining: a maximal amount of THC to be delivered, the amount being 0.75 mg THC or less, and a time period within which that amount is delivered, the time period being 2 hours or longer; a decision module which decides, according to the scheduled regimen, if a delivery should take place; and an inhaler device for delivering THC to the subject, the inhaler device comprising a controller which carries out delivery of THC based on the decision made by the decision module.Type: ApplicationFiled: January 5, 2017Publication date: January 17, 2019Inventors: Perry DAVIDSON, Seth KINDLER, Shlomo ALMOG, Binyamin SCHWARTZ, Aaron SCHORR, Daniella ATZMONY
-
Publication number: 20180318529Abstract: Provided herein is a method of pulmonary delivering to a subject at least one pharmacologically active agent being in a plant material, which is effected by pulmonary delivering the agent to the subject using a metered dose inhaler device that is configured to vaporize at least one pre-determined vaporized amount of the agent upon controllably heating the plant material, wherein the pre-determined vaporized amount is selected so as to achieve at least one pre-determined pharmacokinetic effect and/or at least one pre-determined pharmacodynamic effect induced by the agent in the subject.Type: ApplicationFiled: July 10, 2018Publication date: November 8, 2018Applicant: Syqe Medical Ltd.Inventors: Perry DAVIDSON, Shlomo ALMOG, Seth KINDLER
-
Patent number: 10118006Abstract: Provided herein is a method of pulmonary delivering to a subject at least one pharmacologically active agent being in a plant material, which is effected by pulmonary delivering the agent to the subject using a metered dose inhaler device that is configured to vaporize at least one pre-determined vaporized amount of the agent upon controllably heating the plant material, wherein the pre-determined vaporized amount is selected so as to achieve at least one pre-determined pharmacokinetic effect and/or at least one pre-determined pharmacodynamic effect induced by the agent in the subject.Type: GrantFiled: December 11, 2016Date of Patent: November 6, 2018Assignee: Syqe Medical Ltd.Inventors: Perry Davidson, Shlomo Almog, Seth Kindler
-
Patent number: 9839241Abstract: Provided herein is a system that includes a metered dose inhaler device for pulmonary delivering to a subject at least one pre-determined vaporized amount of at least one pharmacologically active agent being in a plant material, wherein vaporization is effected by controllably heating the plant material so as to vaporize a pre-determined vaporized amount of the agent; the system further includes a controller in communication with the inhaler device, configured to control the pre-determined vaporized amount based on data indicative of at least one pharmacodynamic effect induced by the agent in the subject.Type: GrantFiled: December 21, 2016Date of Patent: December 12, 2017Assignee: Syqe Medical Ltd.Inventors: Perry Davidson, Shlomo Almog, Seth Kindler
-
Publication number: 20170157343Abstract: Provided herein is a method of pulmonary delivering to a subject at least one pharmacologically active agent being in a plant material, which is effected by pulmonary delivering the agent to the subject using a metered dose inhaler device that is configured to vaporize at least one pre-determined vaporized amount of the agent upon controllably heating the plant material, wherein the pre-determined vaporized amount is selected so as to achieve at least one pre-determined pharmacokinetic effect and/or at least one pre-determined pharmacodynamic effect induced by the agent in the subject.Type: ApplicationFiled: December 11, 2016Publication date: June 8, 2017Inventors: Perry DAVIDSON, Shlomo ALMOG, Seth KINDLER
-
Publication number: 20170127727Abstract: Provided herein is a system that includes a metered dose inhaler device for pulmonary delivering to a subject at least one pre-determined vaporized amount of at least one pharmacologically active agent being in a plant material, wherein vaporization is effected by controllably heating the plant material so as to vaporize a pre-determined vaporized amount of the agent; the system further includes a controller in communication with the inhaler device, configured to control the pre-determined vaporized amount based on data indicative of at least one pharmacodynamic effect induced by the agent in the subject.Type: ApplicationFiled: December 21, 2016Publication date: May 11, 2017Inventors: Perry DAVIDSON, Shlomo ALMOG, Seth KINDLER
-
Patent number: 9623000Abstract: Compositions which include a corticosteroid in combination with an additional compound active in treatment of an inflammatory disorder are provided.Type: GrantFiled: July 29, 2009Date of Patent: April 18, 2017Assignee: DEKEL PHARMACEUTICALS LTDInventors: Seth Kindler, Ascher Shmulewitz
-
Publication number: 20110195096Abstract: Compositions which include a corticosteroid in combination with an additional compound active in treatment of an inflammatory disorder are provided.Type: ApplicationFiled: July 29, 2009Publication date: August 11, 2011Applicant: DEKEL PHARMACEUTICALS LTD.Inventors: Seth Kindler, Ascher Shmulewitz
-
Publication number: 20050192341Abstract: The present invention relates to method of using pharmaceutical compositions that contain, as an active ingredient, non-psychotropic cannabinoids for preventing, alleviating or diminishing cognitive impairment resulting from certain types of surgery, diseases or viral infections, fetal distress, pre-term or low weight delivery, from medical intervention such as certain types of medication, irradiation or electroconvulsive therapy, or for prophylactic use in populations exhibiting mild cognitive impairment, and other populations at risk for chronic neurodegenerative diseases.Type: ApplicationFiled: March 4, 2005Publication date: September 1, 2005Inventors: Seth Kindler, Aaron Garzon, George Fink